Evidence map›Paper›PMID 18524939›Full record

ArticleAmerican journal of physiology. Cell physiology2008

Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo.

Yusuke Mizuno, Eiji Isotani, Jian Huang, Hailei Ding, James T Stull, Kristine E Kamm

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Everolimus-induced hyperpermeability of endothelial cells causes lung injury.Experimental biology and medicine (Maywood, N.J.) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Mfge8 attenuates human gastric antrum smooth muscle contractions.Journal of muscle research and cell motility · 2021
    Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Yusuke MizunoDept. Physiology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9040, USA.
Eiji Isotani
Jian Huang
Hailei Ding
James T Stull
Kristine E Kamm
The University of Texas Southwestern Medical Center · US

Funding

MYOSIN LIGHT CHAIN KINASE FUNCTION IN SMOOTH MUSCLER01HL026043 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI STULL, JAMES T · 1985 to 2009
$3.4M
BIOCHEMICAL MECHANISMS OF SMOOTH MUSCLE CONTRACTIONR37HL026043 · NHLBI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI STULL, JAMES T · 1991 to 1999
–
NHLBI NIH HHS HL-26043
6 · The paper itself

Abstract

Ca(2+)/calmodulin (CaM)-dependent phosphorylation of myosin regulatory light chain (RLC) in smooth muscle by myosin light chain kinase (MLCK) and dephosphorylation by myosin light chain phosphatase (MLCP) are subject to modulatory cascades that influence the sensitivity of RLC phosphorylation and hence contraction to intracellular Ca(2+) concentration ([Ca(2+)](i)). We designed a CaM-sensor MLCK containing smooth muscle MLCK fused to two fluorescent proteins linked by the MLCK CaM-binding sequence to measure kinase activation in vivo and expressed it specifically in mouse smooth muscle. In phasic bladder muscle, there was greater RLC phosphorylation and force relative to MLCK activation and [Ca(2+)](i) with carbachol (CCh) compared with KCl treatment, consistent with agonist-dependent inhibition of MLCP. The dependence of force on MLCK activity was nonlinear such that at higher concentrations of CCh, force increased with no change in the net 20% activation of MLCK. A significant but smaller amount of MLCK activation was found during the sustained contractile phase. MLCP inhibition may occur through RhoA/Rho-kinase and/or PKC with phosphorylation of myosin phosphatase targeting subunit-1 (MYPT1) and PKC-potentiated phosphatase inhibitor (CPI-17), respectively. CCh treatment, but not KCl, resulted in MYPT1 and CPI-17 phosphorylation. Both Y27632 (Rho-kinase inhibitor) and calphostin C (PKC inhibitor) reduced CCh-dependent force, RLC phosphorylation, and phosphorylation of MYPT1 (Thr694) without changing MLCK activation. Calphostin C, but not Y27632, also reduced CCh-induced phosphorylation of CPI-17. CCh concentration responses showed that phosphorylation of CPI-17 was more sensitive than MYPT1. Thus the onset of agonist-induced contraction in phasic smooth muscle results from the rapid and coordinated activation of MLCK with hierarchical inhibition of MLCP by CPI-17 and MYPT1 phosphorylation.

Indexed as

AmidesAnimalsCalciumCalcium SignalingCalmodulinCarbacholIntracellular Signaling Peptides and ProteinsIsometric ContractionMiceMice, TransgenicMuscle ContractionMuscle ProteinsMuscle, SmoothMyosin-Light-Chain KinaseMyosin-Light-Chain PhosphataseMyosin Light ChainsAmidesCalciumCalmodulincalphostin CCarbacholIntracellular Signaling Peptides and ProteinsMuscle ProteinsMyosin-Light-Chain KinaseMyosin-Light-Chain PhosphataseMyosin Light ChainsNaphthalenesPhosphoproteinsPotassium ChloridePpp1r12a protein, mousePpp1r14a protein, mouseProtein Kinase CProtein Kinase InhibitorsPyridinesrho-Associated KinasesY 27632

Identifiers

PMID18524939
PMCPMC2518426
OpenAlexW2058326064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.